Experience
AI-Powered Pathology
Demo PathAI's digital pathology solutions for translational research and clinical development
- Analyze routine pathology images such as H&E and IHC with single-cell, spatial resolution
- Extract standardized and structured histopathology features to enable pathology research at scale
- Visualize disease heterogeneity, cell populations, and tissue architectures with high-resolution AI-powered overlays
See for yourself: Quantitative pathology in high-resolution
Ready to enhance your pathology data with AI? Register for a demo account to get a closer look into PathAI's products:
Oncology
- PathExplore™: Spatially-resolved, single cell analysis from H&E
- PathExplore™ IOP: Immune Phenotyping & TIL Characterization
- IHC Explore™: AI-powered biomarker quantification
IBD, Liver & MASH
- IBD Explore™: Spatial, single cell-resolution of the inflammatory microenvironment
- Liver Explore™: Characterizes liver tissue biopsy microarchitecture
Work with PathAI across the drug development lifecycle
Our mission is to improve patient outcomes with AI-powered pathology
PathAI has developed a comprehensive, scalable precision pathology solution for all stages of drug development. We bring together intelligent software platforms with robust AI algorithms leveraging data from our network of >550 US board-certified pathologists and library of millions of annotations and whole slide images.
Our content library
CASE STUDY
AI-Assisted Titer Selection in Early Assay Development
- PathAI deployed IHC Explore on prostate cancer specimens stained with a novel, in-development assay
- IHC Explore quantifies staining intensity at single-cell resolution, enabling rapid assay characterization and titer optimization
- Continuous staining intensity measurement provides added value for next-generation biomarkers and precision medicine strategies
Publication Collections
PathExplore™ , PathExplore™ IOP, IHC Explore™, Liver Explore™, and IBD Explore™ are for research use only. Not for use in diagnostic procedures.